Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Mirum Pharmaceuticals Appoints Dr. Rob Myers As Chief Medical Officer

PUBLIC · MIRMSep 08, 2026•about 2 hours ago

Position

Chief Medical Officer

Company

Mirum Pharmaceuticals, Inc.

Dr. Rob Myers
Foster CityHealthcarePharmaceutical Manufacturing

Description

Mirum Pharmaceuticals has announced the appointment of Dr. Rob Myers as their new Chief Medical Officer. This strategic hire is expected to strengthen the company’s leadership in developing therapies for liver diseases.

Company Information

Company

Mirum Pharmaceuticals, Inc.

Location

950 TOWER LANE, SUITE 1050

Foster City, California, United States

About

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: LIVMARLI® (maralixibat) oral solution, Cholbam® (cholic acid) capsules, and Chenodal® (chenodiol) tablets.

Don't miss Mirum Pharmaceuticals, Inc.'s next move

Get an email the moment Mirum Pharmaceuticals, Inc. changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
Bill
Senior decision-maker at this company
••••••••@••••••••

See Bill's verified email →

Carol
Senior decision-maker at this company
••••••••@••••••••

See Carol's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Mirum Pharmaceuticals, Inc.'s next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Mirum Pharmaceuticals, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.